Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

[Extramedullary relapse of acute lymphoblastic leukemia in the breast after unrelated allogeneic bone marrow transplantation].

Numata A, Tanaka M, Tachibana T, Maruta A, Kanamori H, Ishigatsubo Y, Harada H, Mori H.

Gan To Kagaku Ryoho. 2012 Jul;39(7):1103-5. Japanese.

PMID:
22790047
2.

Isolated breast relapse after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.

Conter V, D'Angelo P, Rovelli A, Uderzo C, Jankovic M, Bratina G, Masera G.

Med Pediatr Oncol. 1992;20(2):165-8.

PMID:
1734223
3.

Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.

Huck K, Laws HJ, Meisel R, Traeger A, Bernbeck B, Schonberger S, Stackelberg VA, Pape H, Dilloo D.

Haematologica. 2006 May;91(5 Suppl):ECR07.

4.

Extramedullary relapse of acute lymphoblastic leukemia in breast: a rare presentation.

Thanka J, Krishnarathinam K, Rajendiran S.

Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):155-6. doi: 10.4103/0377-4929.59212.

5.

Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation.

Au WY, Lie AK, Liang R, Kwong YL.

Bone Marrow Transplant. 1999 Nov;24(10):1137-40.

PMID:
10578164
6.

Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.

Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.

Haematologica. 2000 Nov;85(11 Suppl):47-53. Review.

PMID:
11268324
7.

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.

Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E.

Cancer. 1999 Feb 1;85(3):608-15. Review.

PMID:
10091734
8.

Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.

Hoogerbrugge PM, Gerritsen EJ, vd Does-van den Berg A, vd Berg H, Zwinderman AH, Hermans J, Vossen JM.

Bone Marrow Transplant. 1995 Feb;15(2):255-9.

PMID:
7773215
9.

[Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].

Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.

Sangre (Barc). 1996 Apr;41(2):101-8. Spanish.

PMID:
9045349
10.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.

Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011.

11.
12.

Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation.

Ikeuchi K, Doki N, Takao A, Hishima T, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Intern Med. 2017 Dec 1;56(23):3215-3217. doi: 10.2169/internalmedicine.8646-16. Epub 2017 Sep 25.

13.

Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission.

Ganem G, Kuentz M, Bernaudin F, Gharbi A, Cordonnier C, Lemerle S, Karianakis G, Vinci G, Rochant H, Lebourgeois JP, et al.

Cancer. 1989 Nov 1;64(9):1796-804.

PMID:
2676139
14.

Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion.

Patriarca F, Sperotto A, Skert C, Damiani D, Prosdocimo S, Fanin R.

Ann Hematol. 2004 Oct;83(10):667-9. Epub 2004 Aug 5.

PMID:
15300405
15.

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.

Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B, Reiffers J, Sadoun A, Rohrlich P, Jouet JP, Milpied N, Lutz P, Plouvier E, Cornu G, Vannier JP, Gandemer V, Rubie H, Gratecos N, Leverger G, Stephan JL, Boutard P, Vernant JP.

Br J Haematol. 1998 Aug;102(3):656-65.

PMID:
9722290
16.

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

Knechtli CJ, Goulden NJ, Hancock JP, Grandage VL, Harris EL, Garland RJ, Jones CG, Rowbottom AW, Hunt LP, Green AF, Clarke E, Lankester AW, Cornish JM, Pamphilon DH, Steward CG, Oakhill A.

Blood. 1998 Dec 1;92(11):4072-9.

17.

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E.

Blood. 2001 May 15;97(10):2962-71.

18.

Pleural relapse during hematopoietic remission in childhood acute lymphoblastic leukemia.

Dix DB, Anderson RA, McFadden DE, Wadsworth LD.

J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):470-2.

PMID:
9329473
19.

Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.

Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N.

Bone Marrow Transplant. 1997 Oct;20(7):533-41.

20.

Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL.

Koca E, Goker H, Guven GS, Cetiner D, Haznedaroglu IC, Buyukasik Y, Uner A, Ozcebe OI.

Hematology. 2006 Apr;11(2):105-7.

PMID:
16753850

Supplemental Content

Support Center